Market News / Story
Unicycive Therapeutics, Inc. Stock 12‑Month Price Target Raised to $29.56, Implies 599% Upside
·
According to estimates from 9 analysts, Unicycive Therapeutics, Inc. stock's average price target has risen from $28.4 to $29.56, with forecasts ranging from $13 to $42 per share Based on the Oct. 6 closing price, the updated target implies approximately 599% potential upside Consensus rating remains at “Buy” across 9 covering analysts, with 9 Buys, 0 Holds and 0 Sells Explore more price target data and ratings for Unicycive Therapeutics, Inc. on the Forecasts tab , and…